Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group

Dorte Lisbet Nielsen, Karsten D Bjerre, Erik H Jakobsen, Søren Cold, Lars Eric Stenbygaard, Peter G Sørensen, Claus Kamby, Susanne Møller, Charlotte L T Jørgensen, Michael Andersson

27 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science